Article related to AstraZeneca | AWANI International
LIVE
Videos
US-China
BRICS-RT
ASEAN
West Asia
Shows
Podcast
BM
EN
LIVE
Login
BM
EN
LIVE
Login
LIVE
Videos
US-China
BRICS-RT
ASEAN
West Asia
Shows
Podcast
Putin and Modi discuss trade, peace in New Delhi summit
Taiwan, Japan voice concern over Chinese military movements
Venezuela to face severe medicine shortage due to US sanctions, flight suspensions
AstraZeneca
US to initially impose 'small tariff' on pharma imports, Trump says
06/08/2025
Tariff wars to hit popular US-made drugs in China, regulator data shows
15/04/2025
Malaysia to seek AstraZeneca explanation about COVID-19 vaccine side effect - MOH
03/05/2024
Tengku Zafrul meets AstraZeneca chairman to discuss potential expansion in Malaysia
21/01/2023
Study confirms AstraZeneca jab's higher risk of very rare clot
28/10/2022
AstraZeneca's COVID vaccine suffers a setback in nasal spray trial
11/10/2022
New antibody therapies fight cancer, drum up investment
26/06/2022
COVID vaccine makers shift focus to boosters
10/05/2022
The world of vaccines, before and after COVID
26/04/2022
FACTBOX - Latest on the worldwide spread of the coronavirus
24/03/2022
COVID SCIENCE - Most unvaccinated children lack antibodies after COVID; SK Bioscience vaccine shows promise vs Omicron
22/03/2022
Any booster is better than no booster, says Khairy
12/02/2022
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - Study
25/01/2022
Booster dose interval cut to three months for Pfizer, AstraZeneca vaccine recipients
28/12/2021
Ecuador mandates jabs, Italy to enforce masks outdoors as Omicron rages
24/12/2021
More contagious, less severe: What we know about Omicron
24/12/2021
AstraZeneca vaccine booster shot effective against Omicron - Oxford lab study
23/12/2021
Boosters may prolong COVID WHO warns, France jabs kids as Omicron surges
23/12/2021
Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations
15/12/2021
Malaysia donates AstraZeneca vaccines to Bangladesh, Laos
06/12/2021
Show More
